KRISTEN DOSTIE Alteration of Chemotaxis in the Gut of IBD Patients.

Slides:



Advertisements
Similar presentations
Eddie Dominguez Micro 790 March Today’s adventure entails… Overview of Entamoeba histolytica Colon epithelial tissue Extracellular Matrix Matrix.
Advertisements

Opportunistic Bacterial Infections in Inflammatory Bowel Disease By: Christina Philips.
Ursodeoxycholic acid inhibits colonic mucosal cytokine release and prevents colitis in a mouse model of disease Joseph BJ Ward 1, Orlaith Kelly 1,2, Siobhan.
JAIMEE DOUCETTE T HELPER CELLS IN IBD. OVERVIEW Background Information on T Helper cells What is known about Th cells in IBD? What is still unknown about.
Overexpression of MMP9 in colonic epithelium mediates protection in colitis associated cancer PALLAVI GARG Ph.D.
CHRONIC OBSTRUCTIVE PULMONARY DISEASE ZULEYHA OZEN.
1 Modulation of inflammatory processes in DSS-induced colitis model versus gastrointestinal acute radiation syndrome with AVX-470m, an oral polyclonal.
Musketeers Course October The Mucosal Immune System The organization of the mucosal immune systemThe organization of the mucosal immune system The.
Chemical Toxicants and Chronic Inflammation Kristen Dostie April 8, 2015.
Lecture 16 Allergy Hay fever 20% Asthma ~5%. Figure 10-1.
Chapter 13 Leukocyte Activation and Migration Dr. Capers
P1586 THE FIRST JAK1-SELECTIVE INHIBITOR, FILGOTINIB, DISPLAYS SIMILAR MOLECULAR ACTIVITY IN THE GUT OF MICE WITH DSS-INDUCED COLITIS AND IN CULTURES OF.
The complement system is a biochemical cascade that helps, or “complements”, the ability of antibodies to clear pathogens from an organism. It is part.
Chapter 10. Cell-mediated immunity (CMI) is the type of host defense that is mediated by T lymphocytes, and it serves as a defense mechanism against.
Adenosine Protects Vascular Barrier Function in Hyperoxic Lung Injury Jonathan Davies 1, Harry Karmouty-Quintana 2, Thuy T. Le 2, Ning-Yuan Chen 2, Tingting.
Identification of a Novel Substance P–Neurokinin-1 Receptor MicroRNA-221-5p Inflammatory Network in Human Colonic Epithelial Cells  Kai Fang, Aristea.
Immunity in the Gut Andrew M. Platt, University of Glasgow, UK
* * * * * * * Results Abstract Description of intervention/study
Laboratory of cellular immunology
Chemokines: Introduction
Experimental Models of Inflammatory Bowel Diseases
Current concepts of celiac disease pathogenesis
Volume 31, Issue 3, Pages (September 2009)
Volume 136, Issue 2, Pages e5 (February 2009)
Volume 380, Issue 9853, Pages (November 2012)
Volume 130, Issue 1, Pages (January 2006)
Inflammation and Colon Cancer
Bridget A. Robinson, Timothy J. Nice  Immunity 
Road signs guiding leukocytes along the inflammation superhighway
Microbial Influences in Inflammatory Bowel Diseases
Tumor necrosis factor: Biology and therapeutic inhibitors
Roles for Chemokines in Liver Disease
Volume 145, Issue 2, Pages e10 (August 2013)
Volume 17, Issue 6, Pages (December 2002)
Benoit Chassaing, Arlette Darfeuille–Michaud  Gastroenterology 
Nat. Rev. Nephrol. doi: /nrneph
Volume 145, Issue 2, Pages e10 (August 2013)
Galectin-1 suppresses experimental colitis in mice
Pathogenic Escherichia coli in inflammatory bowel diseases
Innate immunity in cystic fibrosis lung disease
No Ameliorating Effect of Surfactant Protein D on DSS-Induced Colitis in Mice Anders B. Nexoe1, Bartosz Pilecki1, Mathias Rathe2, Steffen Husby2, Uffe.
Immunity to Infectious Diseases
Figure 4 TNFSF inflammatory activities in tissue cells
Volume 136, Issue 2, Pages (February 2009)
Volume 21, Issue 4, Pages (October 2017)
Volume 139, Issue 6, Pages (December 2010)
Volume 140, Issue 2, Pages e4 (February 2011)
Dietmar M.W. Zaiss, William C. Gause, Lisa C. Osborne, David Artis 
Volume 125, Issue 6, Pages (December 2003)
Bridging immunity and lipid metabolism by gut microbiota
Therapeutic Action of Ghrelin in a Mouse Model of Colitis
Figure 2 The hypoxia-induced proinflammatory
Chengcheng Jin, Jorge Henao-Mejia, Richard A. Flavell  Cell Metabolism 
Gregory B. Vanden Heuvel  Kidney International 
Mechanisms of Disease: Inflammatory Bowel Diseases
Wenjun Ouyang, Jay K. Kolls, Yan Zheng  Immunity 
Blockade of poly(ADP-ribose) synthetase inhibits neutrophil recruitment, oxidant generation, and mucosal injury in murine colitis  Basilia Zingarelli,
Volume 132, Issue 3, Pages (March 2007)
Inflammasomes in Intestinal Inflammation and Cancer
Chemokine Receptors in T-Cell-Mediated Diseases of the Skin
Volume 21, Issue 4, Pages (October 2017)
Volume 132, Issue 2, Pages (February 2007)
Inflammation in Wound Repair: Molecular and Cellular Mechanisms
NODding off in acute kidney injury with progranulin?
Volume 136, Issue 7, Pages (June 2009)
Chemokines: Key Players in Innate and Adaptive Immunity
Volume 31, Issue 3, Pages (September 2009)
Tumor necrosis factor: Biology and therapeutic inhibitors
Epithelial mechanisms of vitamin D: (1) increased VDR activity is shown to repress NF-κB-dependent epithelial apoptosis pathways in experimental colitis.
Dietmar M.W. Zaiss, William C. Gause, Lisa C. Osborne, David Artis 
Presentation transcript:

KRISTEN DOSTIE Alteration of Chemotaxis in the Gut of IBD Patients

Overview Introduction What do we know about neutrophil chemotaxis in IBD? Paper 1 Paper 2 What is still unknown about neutrophil chemotaxis in IBD? Specific Aim

The Inflammatory Response

How are neutrophils recruited from the bloodstream to the affected area? CXC chemokines are ligands for CXCR receptors on several different cell types Promote neutrophil migration Chemotaxis!  Movement of a cell in response to a chemical stimulus

Neutrophil infiltration is largely mediated through binding of CXCR receptors Nature Reviews Immunology 13, 649–665 (2013)

Overview Introduction What do we know about neutrophil chemotaxis in IBD? What is still unknown about neutrophil chemotaxis in IBD? Paper 1 Paper 2 Specific Aims

What is generally known about neutrophil chemotaxis in IBD? Invasion of neutrophils into the mucosal epithelium and intestinal lumen correlates with disease activity Neutrophil infiltration disrupts epithelial barrier integrity  Allows lumenal proteins and microorganisms to breach the submucosa Neutrophils within the mucosa and submucosa produce proinflammatory signals that perpetuate neutrophil recruitment to the affected area

What is generally known about neutrophil chemotaxis in IBD? Neutrophils release a plethora of inflammatory mediators that can exacerbate inflammation Inflammatory Bowel Disease. Volume 19, Number 7, June 2013

Overview Introduction What do we know about neutrophil chemotaxis in IBD? Paper 1 Paper 2 What is still unknown about neutrophil chemotaxis in IBD? Specific Aims

Paper 1

Paper 1 Background Neutrophils produce proteases that cleave collagen into proline- glycine-proline (PGP)  Matrix metalloproteinases (MMPs)  Prolyl endopeptidase (PE) PGP has been shown to be a chemoattractant for neutrophils via CXCR1/2 in several lung diseases Goal: to investigate the role of PGP in neutrophil recruitment associated with IBD

Figure 1: Is protease expression upregulated in the colon of IBD patients? Conclusions: MMP8 is upregulated in both inflamed and non- inflamed IBD intestinal samples MMP8 present in IBD patients exists dominantly in its active form

Figure 1 (cont’d): Where do these proteases localize within the intestine? MMP9: neutrophils PE: neutrophils and epithelial cells MMP8: weak expression in neutrophils and inflammatory cells

Figure 2: Are products of MMP and PE activity increased in IBD? N-Ac-PGP (an acetylated form of PGP) expression is increased in IBD patient intestinal samples.

Figure 3: Do IBD neutrophils produce more proteases and their subsequent products compared to healthy controls? Proteases Chemoattractants Conclusion: IBD neutrophils produce significantly higher levels of MMP8, MMP9, and N-Ac-PGP in conditioned medium

Figure 4: Protease expression in a DSS- induced colitis model PE: no significant difference in expression MMP9: significant increase in expression MMP8: no significant difference in expression Conclusion: protease expression in DSS-induced colitis colon samples is comparable to human IBD tissue levels.

Figure 5: Localization of protease expression in DSS-induced colitis colon tissue MMP8: leukocytes and epithelial cells MMP9: leukocytes PE: leukocytes and epithelial cells Conclusion: localization of proteases is comparable to patterns in human disease.

Figure 5 (cont’d): Chemoattractant expression in DSS-colitis colon tissue Conclusion: N-Ac-PGP and PGP are generated in DSS colon samples, but not at significant levels.

Figure 6: PGP neutralization as a therapeutic for IBD Conclusion: PGP neutralization reduced disease activity index (DAI), shortening of the colon, histopathological scores, and neutrophil infiltration in the colon.

Figure 7: The PGP generation cascade leads to neutrophil chemotaxis

Conclusions from Paper 1 Components of the PGP generation pathway (matrix metalloproteinases and PE) are present in intestines of human IBD patients and DSS-induced colitis mice. N-Ac-PGP-mediated neutrophil recruitment likely plays a role in the perpetuation of intestinal inflammation of IBD PGP neutralization reduced neutrophil infiltration and disease activity indices in a DSS-induced colitis model

Overview Introduction What do we know about neutrophil chemotaxis in IBD? Paper 1 Paper 2 What is still unknown about neutrophil chemotaxis in IBD? Specific Aim

Paper 2

Lumican Found in connective tissue rich in fibrillar collagens Deficiency impairs connective tissue function Promotes neutrophil migration by interacting with neutrophil migration receptor MAC1 or CD11b or CD18 Expression is upregulated in epithelial cells after injury Goal: characterize the role of lumican in regulating immune response during inflammation

Figure 1: Summary of TNBS colitis model

Figure 2: Response to intrarectal TNBS treatment using saline or ethanol as controls Conclusion: Lum -/- TNBS-treated mice displayed more pronounced adverse effects to TNBS treatment than the WT strain.

Figure 3: Macroscopic appearance of Lum +/+ and Lum -/- colons from saline vs. TNBS-treated mice

Figure 4: Increased inflammation of colons in Lum +/+ and Lum -/- mice Conclusion: colonic edema and swelling is increased in Lum-/- mice.

Figure 5: Is early acute inflammatory response T cell-mediated or innate immune driven? Conclusion: Early stages of TNBS induced colitis involves an innate immune response Rag1 -/- mice do not have mature B or T cells.

Figure 6: Histology of colon cross sections from Lum +/+ and Lum -/- mice

Figure 7: Inflammation scores and MPO expression Conclusion: Lum-/- colons have more tissue damage but less neutrophil infiltration after TNBS colitis induction.

Figure 8: Induction of proinflammatory cytokines in inflamed colonic tissue Conclusion: TNBS colitis induced CXCL1/KC and TNFα production in Lum+/+ but not Lum-/- colonic tissue.

Figure 9: NF-κB activation in Lum +/+ vs. Lum -/- mice 1 º peritoneal cells Conclusion: delayed nuclear localization of NF-κB in Lum -/- colonic samples suggests a weak innate immune response in the absence of lumican.

Conclusions from Paper 2 Lumican deficiency leads to decreased neutrophil infiltration but increased severity of colitis Lumican plays a role in regulation of inflammation in colitis  CXCL1  TNF-α  Neutrophil recruitment

What is still unknown about neutrophil chemotaxis in IBD? Well, a lot of things. ECM proteins and their degradation products  Several are ECM proteins are upregulated in inflamed colonic tissue of IBD patients  Neutrophils themselves produce proteases whose products further perpetuate their infiltration Role of upregulated ECM proteins in the perpetuation of neutrophil infiltration in IBD is poorly studied. Mechanism of action of ECM proteins/protease products on neutrophil recruitment is poorly understood

Specific Aim and Future Directions Specific Aim  Determine a set of ECM proteins and their degradation products upregulated in inflamed colonic tissue in IBD that can be chemoattractants for neutrophils Potential experiments  Electric cell-substrate impedance sensing (ECIS)/Taxis to determine potency of chemoattraction induced by various ECM proteins and degradation products  Determine mechanism of action of these proteins by blocking CXCR receptors

Thanks for listening!